Hydroxypropylbetadex

(BAN, USAN, rINN)

Chemical information

Pharmacopoeias.

In Eur.. Also in USNF.

Ph. Eur. 6.2

(Hydroxypropylbetadex). A white or almost white, amorphous or crystalline powder. Freely soluble in water and in propylene glycol.

USNF 26

(Hydroxypropyl Betadex). A white or almost white, amorphous or crystalline powder. Freely soluble in water and in propylene glycol.

Profile

Cyclodextrins, such as alfadex and betadex, are produced by the enzymatic degradation of starch and are used as carrier molecules for drug delivery systems. Hydroxypropylbetadex, a derivative of betadex, is also used.
1. Ridgway K. Drug release rates: cyclodextrin complexes. Pharm J 1990; 245: 344–5
2. Szejtli J. Cyclodextrins: properties and applications. Drug Invest 1990; 2 (suppl 4): 11–21
3. El Shaboury MH. Physical properties and dissolution profiles of tablets directly compressed with β-cyclodextrin. Int J Pharmaceutics 1990; 63: 95–100
4. Stella VJ, Rajewski RA. Cyclodextrins: their future in drug formulation and delivery. Pharm Res 1997; 14: 556–67
5. Loftsson T, Olafsson JH. Cyclodextrins: new drug delivery systems in dermatology. Int J Dermatol 1998; 37: 241–6
6. Redenti E, et al. Drug/cyclodextrin/hydroxy acid multicomponent systems: properties and pharmaceutical applications. J Pharm Sci 2000; 89: 1–8
7. Loftsson T, Masson M. Cyclodextrins in topical drug formulations: theory and practice. Int J Pharm 2001; 225: 15–30
8. Loftsson T, Stefansson E. Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. Acta Ophthalmol Scand 2002; 80: 144–50
9. Dass CR. Cyclodextrins and oligonucleotide delivery to solid tumours. J Drug Target 2004; 12: 1–9
10. Kaur IP, et al. Role of cyclodextrins in ophthalmics. Curr Drug Deliv 2004; 1: 351–60
11. Challa R, et al. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech 2005; 6: E329–E357.
Published May 08, 2019.